Cargando…
Enhanced Safety Surveillance of Influenza Vaccines in General Practice, Winter 2015-16: Feasibility Study
BACKGROUND: The European Medicines Agency (EMA) requires vaccine manufacturers to conduct enhanced real-time surveillance of seasonal influenza vaccination. The EMA has specified a list of adverse events of interest to be monitored. The EMA sets out 3 different ways to conduct such surveillance: (1)...
Autores principales: | de Lusignan, Simon, Correa, Ana, Dos Santos, Gaël, Meyer, Nadia, Haguinet, François, Webb, Rebecca, McGee, Christopher, Byford, Rachel, Yonova, Ivelina, Pathirannehelage, Sameera, Ferreira, Filipa Matos, Jones, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913774/ https://www.ncbi.nlm.nih.gov/pubmed/31724955 http://dx.doi.org/10.2196/12016 |
Ejemplares similares
-
Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
por: de Lusignan, Simon, et al.
Publicado: (2020) -
Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card
por: de Lusignan, Simon, et al.
Publicado: (2019) -
Incidence of Lower Respiratory Tract Infections and Atopic Conditions in Boys and Young Male Adults: Royal College of General Practitioners Research and Surveillance Centre Annual Report 2015-2016
por: de Lusignan, Simon, et al.
Publicado: (2018) -
Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: protocol of a pilot study in England
por: de Lusignan, Simon, et al.
Publicado: (2017) -
Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis
por: de Lusignan, Simon, et al.
Publicado: (2018)